MULTIPLE ENDOCRINE NEOPLASIA TYPE 1 AND ADRENAL LESIONS
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
PURPOSE: We investigated the relationship of long-term pancreatic hormone hypersecretion with adrenal lesions in patients with multiple endocrine neoplasia type 1 and in those with sporadic pancreatic endocrine tumors. MATERIALS AND METHODS: We assessed the prevalence of adrenal lesions in 20 patients with multiple endocrine neoplasia type 1 and in a control group of 12 with sporadic pancreatic endocrine tumors. We also performed genetic testing for germline mutations of MEN1, the multiple endocrine neoplasia type 1 gene. RESULTS: Adrenal lesions were common in multiple endocrine neoplasia type 1, accounting for 35% of cases. All adrenal lesions were nonfunctioning and benign. The relative risk of adrenal tumors was higher in patients with multiple endocrine neoplasia type 1 than in controls (p <0.05). No apparent relationship was observed of hormonal pattern or genotype with adrenal disease. CONCLUSIONS: Hormone hypersecretion by pancreatic endocrine tumors is not the primary cause of the development of adrenal lesions and the role of the MEN1 gene in adrenal tumorigenesis remains unclear. Adrenal lesions follow a benign course in most multiple endocrine neoplasia type 1 cases but careful morphological and functional followup is advisable.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adrenal lesion in multiple endocrine neoplasia type 1
Skogseid, B., Rastad, J., Gobl, A., Larsson, C., Backlin, K., Juhlin, C., Åkerström, G., & Öberg, K. (1995) · Surgery · doi:10.1016/s0039-6060(05)80117-5 · Cited by 111
Cited by
Prevalence and natural history of adrenal incidentalomas
Barzon, L., Sonino, N., Fallo, F., Palu, G., & Boscaro, M. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1490273 · Cited by 642
Self-citationGibril, F., Schumann, M., Pace, A., & Jensen, R. T. (2004) · Medicine · doi:10.1097/01.md.0000112297.72510.32 · Cited by 313
Gatta-Cherifi, B., Chabre, O., Murat, A., Niccoli, P., Cardot-Bauters, C., Rohmer, V, Young, J., Delemer, B., Du Boullay, H., Verger, M. F., et al. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-0679 · Cited by 230
Adrenal involvement in multiple endocrine neoplasia type 1: results of 7 years prospective screening
Waldmann, J., Bartsch, D. K., Kann, P. H., Fendrich, V., Rothmund, M., & Langer, P. (2007) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-006-0124-7 · Cited by 104
Griniatsos, J. E., Dimitriou, N., Zilos, A., Sakellariou, S., Evangelou, K., Kamakari, S., Korkolopoulou, P., & Kaltsas, G. (2011) · World Journal of Surgical Oncology · doi:10.1186/1477-7819-9-6 · Cited by 22
“The incidence of adrenal lesions in MEN1 patients varies between 9 and 45% [14-20] and they usually develop in patients with mutations in exons 2 and 10 [18].”
Background
Metadata
- Authors
- BARZON, L., PASQUALI, C., GRIGOLETTO, C., PEDRAZZOLI, S., BOSCARO, M., & FALLO, F.
- Venue
- Journal of Urology
- Published
- 2001-07
- Volume
- 166
- Issue
- 1
- Pages
- 24-27
- ISSN
- 0022-5347 (ISSN-L)
- 1527-3792
- OpenAlex
- W2047563579
- Cited by
- 44
- References
- 1
- FWCI
- 2.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: MULTIPLE ENDOCRINE NEOPLASIA TYPE 1 AND ADRENAL LESIONS. https://app.cochat.ai/papers/10.1016/s0022-5347(05)66068-5
- The paper
- BARZON, L., PASQUALI, C., GRIGOLETTO, C., PEDRAZZOLI, S., BOSCARO, M., & FALLO, F. (2001). MULTIPLE ENDOCRINE NEOPLASIA TYPE 1 AND ADRENAL LESIONS. Journal of Urology. https://doi.org/10.1016/s0022-5347(05)66068-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.